Studies have confirmed that in non-small cell lung cancer, exosomal miR-338-3p down-regulates CHL1 expression by inhibiting the activation of the MAPK signalling pathway, thereby inhibiting tumour cell metastasis [44]. Here, CHL1 is linked to neoplasm.